Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 19/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8705082 | 0.99 | TACR1 (0.51) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| Hydrochloric Acid SCHEMBL7820198 | 0.81 | TACR1 (0.49) | TACR1CYP2D6HTR1AHTR2AHTR2C | |
| SCHEMBL6555227 | 0.77 | TACR1 (0.80) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL6555215 | 0.77 | TACR1 (0.80) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL6555223 | 0.77 | TACR1 (0.80) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL6098979 | 0.74 | TACR1 (0.58) | TACR1CYP2D6KCNH2 | |
| SCHEMBL6098039 | 0.74 | TACR1 (0.58) | TACR1CYP2D6KCNH2 | |
| SCHEMBL6098977 | 0.74 | TACR1 (0.58) | TACR1CYP2D6KCNH2 | |
| SCHEMBL6098046 | 0.74 | TACR1 (0.58) | TACR1CYP2D6KCNH2 | |
| SCHEMBL7250070 | 0.74 | TACR1 (0.54) | TACR1CYP2D6KCNH2HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5547964-A | ANTIEMETIC DURING DRUG THERAPY | GLAXO GROUP LIMITED (GB) | 1996-08-20 | — | — | US | claimed |
| EP-0615751-A1 | Use of tachykinin antagonists in the treatment of emesis | GLAXO GROUP LIMITED (GB) | 1994-09-21 | — | — | EP | claimed |